Satsuma Pharmaceuticals Inc (STSA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2008 | 06-2008 | 03-2008 | 12-2007 | 09-2007 | |
| Interest Income | 176,327 | 180,642 | 188,983 | 198,097 | 199,918 |
| Interest Expense | 86,319 | 86,523 | 96,896 | 106,057 | 106,254 |
| Interest Income (Net of Interest Expense) | 90,008 | 94,119 | 92,087 | 92,040 | 93,664 |
| Non-Interest Income | 23,019 | 25,498 | 21,162 | 20,973 | 24,207 |
| Sales | 113,027 | 119,617 | 113,249 | 113,013 | 117,871 |
| Credit Losses Provision | 36,950 | 30,987 | 37,143 | 13,000 | 3,888 |
| Non Interest Expenses | 71,520 | 72,447 | 72,107 | 75,801 | 74,104 |
| Pre-tax Income | 4,557 | 16,183 | 3,999 | 24,212 | 39,879 |
| Income Tax | -441 | 4,508 | 1,123 | 7,355 | 13,349 |
| Other Income | 90,876 | 102,706 | 100,895 | 130,269 | 146,133 |
| Net Income | $4,998 | $11,675 | $2,876 | $16,857 | $26,530 |
| EPS Basic Continuous Ops | 6.35 | 14.86 | 3.67 | 21.23 | 34.04 |
| EPS Basic Total Ops | 6.58 | 15.13 | 3.95 | 20.39 | 34.21 |
| EPS Diluted Continuous Ops | 6.32 | 14.80 | 3.65 | 21.19 | 33.79 |
| EPS Diluted Total Ops | 6.58 | 15.13 | 3.95 | 21.71 | 33.55 |
| EBITDA(a) | $N/A | $N/A | $N/A | $N/A | $N/A |